DORATIQ Trademark

Trademark Overview

On Tuesday, November 14, 2017, a trademark application was filed for DORATIQ with the United States Patent and Trademark Office. The USPTO has given the DORATIQ trademark a serial number of 87684061. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 4, 2021. This trademark is owned by pSivida US, Inc.. The DORATIQ trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of diseases and conditions, including ocular diseases, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease, and glaucoma and diseases and conditions in joints, namely, osteoarthritis, bursitis, fibrotic diseases, and infections

Sustained drug delivery systems for pharmaceuticals
doratiq

General Information

Serial Number87684061
Word MarkDORATIQ
Filing DateTuesday, November 14, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 4, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 3, 2018

Trademark Statements

Goods and ServicesDrug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of diseases and conditions, including ocular diseases, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease, and glaucoma and diseases and conditions in joints, namely, osteoarthritis, bursitis, fibrotic diseases, and infections
Goods and ServicesSustained drug delivery systems for pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 27, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, November 27, 2017
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEYEPOINT PHARMACEUTICALS US, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressWATERTOWN, MA 02472
Party NamepSivida US, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472
Party NamepSivida US, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events

Event DateEvent Description
Monday, January 4, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 4, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, October 29, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 29, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 29, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, October 29, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 29, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 29, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 26, 2020SOU EXTENSION 4 GRANTED
Wednesday, February 26, 2020SOU EXTENSION 4 FILED
Wednesday, February 26, 2020TEAS EXTENSION RECEIVED
Friday, August 23, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2019SOU EXTENSION 3 GRANTED
Wednesday, August 21, 2019SOU EXTENSION 3 FILED
Wednesday, August 21, 2019TEAS EXTENSION RECEIVED
Friday, April 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 24, 2019SOU EXTENSION 2 GRANTED
Wednesday, April 24, 2019SOU EXTENSION 2 FILED
Wednesday, April 24, 2019TEAS EXTENSION RECEIVED
Thursday, September 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 25, 2018SOU EXTENSION 1 GRANTED
Tuesday, September 25, 2018SOU EXTENSION 1 FILED
Tuesday, September 25, 2018TEAS EXTENSION RECEIVED
Tuesday, May 29, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 18, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, April 3, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 3, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 27, 2018DATA MODIFICATION COMPLETED
Tuesday, February 27, 2018ASSIGNED TO LIE
Tuesday, February 27, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 27, 2018ASSIGNED TO EXAMINER
Thursday, December 7, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 7, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 27, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 17, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

doratiq diseases delivery macular pharmaceuticals conditions namely drug disease retinal edema